COR – Cencora Inc

COR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.54

Margin Of Safety %

Put/Call OI Ratio

0.62

EPS Next Q Diff

1.43

EPS Last/This Y

9.6

EPS This/Next Y

2.02

Price

309.89

Target Price

412.42

Analyst Recom

1.65

Performance Q

-9.12

Upside

-41.0%

Beta

0.74

Ticker: COR

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	COR	361.75	0.71	3.05	16362
2026-03-10	COR	352.22	0.72	0.07	16386
2026-03-11	COR	350.22	0.70	1.08	16695
2026-03-12	COR	352.59	0.69	1.16	16723
2026-03-13	COR	352.65	0.69	1.20	16723
2026-03-17	COR	334.59	0.68	0.31	16969
2026-03-18	COR	325.04	0.66	0.34	17345
2026-03-19	COR	331.75	0.65	0.06	17922
2026-03-20	COR	327.09	0.64	0.15	18358
2026-03-23	COR	320.67	0.62	0.46	14304
2026-03-24	COR	327.38	0.62	0.89	14456
2026-03-25	COR	325.04	0.61	0.92	14636
2026-03-26	COR	318.03	0.61	0.97	14822
2026-03-27	COR	312.39	0.62	1.94	14922
2026-03-30	COR	309.93	0.62	0.54	15133
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	COR	372.65	7.5	1281.5	17.62
2026-03-03	COR	371.45	7.5	1263.5	17.62
2026-03-04	COR	368.27	7.5	1242.9	17.62
2026-03-05	COR	359.40	7.5	1183.1	17.62
2026-03-06	COR	358.39	7.5	1265.2	17.62
2026-03-09	COR	361.79	7.5	1312.2	17.62
2026-03-10	COR	352.39	7.5	1174.9	17.62
2026-03-11	COR	350.32	7.5	1255.5	17.62
2026-03-12	COR	352.76	7.5	1303.4	17.62
2026-03-13	COR	350.05	7.5	1247.4	17.62
2026-03-17	COR	334.85	7.5	1152.3	17.62
2026-03-18	COR	325.04	7.5	1164.1	17.62
2026-03-19	COR	331.74	7.5	809.3	17.62
2026-03-20	COR	326.97	7.5	693.1	17.62
2026-03-23	COR	320.71	7.5	677.7	17.62
2026-03-24	COR	327.27	7.5	811.3	17.62
2026-03-25	COR	325.19	7.5	720.1	17.62
2026-03-26	COR	318.00	7.5	668.2	17.62
2026-03-27	COR	312.46	7.5	682.7	17.62
2026-03-30	COR	309.89	7.5	714.0	17.62
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

16 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-06	COR	-8.57	1.03	2.77
2026-03-09	COR	-8.56	1.02	2.77
2026-03-10	COR	-8.56	1.02	2.77
2026-03-11	COR	-8.56	1.02	2.45
2026-03-12	COR	-8.56	1.02	2.45
2026-03-13	COR	-8.56	1.02	2.45
2026-03-17	COR	-8.57	1.03	2.45
2026-03-18	COR	-8.56	1.03	2.45
2026-03-19	COR	-5.07	1.03	2.45
2026-03-20	COR	-5.07	1.03	2.45
2026-03-23	COR	-4.47	1.14	2.45
2026-03-24	COR	-4.47	1.14	2.45
2026-03-25	COR	-4.47	1.14	2.54
2026-03-26	COR	-4.47	1.14	2.54
2026-03-27	COR	-4.47	1.14	2.54
2026-03-30	COR	-4.47	1.15	2.54
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

16 items 1 of 1

Last Quarter Act. EPS

2.87

Avg. EPS Est. Current Quarter

4.75

Avg. EPS Est. Next Quarter

4.3

Insider Transactions

-4.47

Institutional Transactions

1.15

Beta

0.74

Average Sales Estimate Current Quarter

81363

Average Sales Estimate Next Quarter

87337

Fair Value

360.25

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.9

Max Drawdown 5-Year %

-17.8

Target Price

412.42

P/E

37.28

Forward P/E

15.84

PEG

1.48

P/S

0.19

P/B

31.59

P/Free Cash Flow

16.71

EPS

8.31

Average EPS Est. Cur. Y

17.62

EPS Next Y. (Est.)

19.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.5

Relative Volume

0.89

Return on Equity vs Sector %

57.7

Return on Equity vs Industry %

-252.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

714

◆ COR Healthcare

$309.93

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

7/15

Valuation

20/20

TP/AR

1/10

Options

4/10

RSI

27.9

Range 1M

0.2%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

17/25

Growth

13/30

Estimates

5/20

Inst/Vol

4/15

Options

4/10

EPS Yr

10.2%

EPS NY

11%

52W%

38%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +31.2% upside

Quality

15/30

Valuation

15/30

Growth

9/25

Stability

4/10

LT Trend

3/5

Upside

+31.2%

Quality

MoS

16%

Cencora, Inc.

Sector: Healthcare

Industry: Medical Distribution

Employees: 47000

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

COR

Latest News

—

Caricamento notizie per COR…

stock quote shares COR – Cencora Inc Stock Price stock today

news today COR – Cencora Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch COR – Cencora Inc yahoo finance google finance

stock history COR – Cencora Inc invest stock market

stock prices COR premarket after hours

ticker COR fair value insiders trading

AHG – Akso Health Group

AHG — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.21

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.34

Target Price

Analyst Recom

Performance Q

67.87

Upside

-360.0%

Beta

-1.05

Ticker: AHG

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	AHG	1.25	N/A	N/A	0
2026-03-03	AHG	1.5	N/A	N/A	0
2026-03-04	AHG	1.31	N/A	N/A	0
2026-03-05	AHG	1.32	N/A	N/A	0
2026-03-06	AHG	1.31	N/A	N/A	0
2026-03-09	AHG	1.48	N/A	N/A	0
2026-03-10	AHG	1.68	N/A	N/A	0
2026-03-11	AHG	2.13	N/A	N/A	0
2026-03-12	AHG	2.18	N/A	N/A	0
2026-03-13	AHG	2.18	N/A	N/A	0
2026-03-17	AHG	2.31	N/A	N/A	0
2026-03-18	AHG	2.44	N/A	N/A	0
2026-03-19	AHG	2.38	N/A	N/A	0
2026-03-20	AHG	2.36	N/A	N/A	0
2026-03-23	AHG	2.34	N/A	N/A	0
2026-03-24	AHG	2.28	N/A	N/A	0
2026-03-25	AHG	2.36	N/A	N/A	0
2026-03-26	AHG	2.37	N/A	N/A	0
2026-03-27	AHG	2.38	N/A	N/A	0
2026-03-30	AHG	2.3	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	AHG	1.35	-	-	-
2026-03-03	AHG	1.36	-	-	-
2026-03-04	AHG	1.38	-	-	-
2026-03-05	AHG	1.35	-	-	-
2026-03-06	AHG	1.31	-	-	-
2026-03-09	AHG	1.41	-	-	-
2026-03-10	AHG	1.66	-	-	-
2026-03-11	AHG	2.13	-	-	-
2026-03-12	AHG	2.16	-	-	-
2026-03-13	AHG	2.24	-	-	-
2026-03-17	AHG	2.32	-	-	-
2026-03-18	AHG	2.40	-	-	-
2026-03-19	AHG	2.38	-	-	-
2026-03-20	AHG	2.35	-	-	-
2026-03-23	AHG	2.34	-	-	-
2026-03-24	AHG	2.23	-	-	-
2026-03-25	AHG	2.36	-	-	-
2026-03-26	AHG	2.26	-	-	-
2026-03-27	AHG	2.31	-	-	-
2026-03-30	AHG	2.34	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	AHG	0	10.99	0.07
2026-03-03	AHG	0	10.99	0.07
2026-03-04	AHG	0	10.99	0.07
2026-03-05	AHG	0	10.99	0.07
2026-03-06	AHG	0	10.99	0.07
2026-03-09	AHG	0	10.87	0.07
2026-03-10	AHG	0	10.87	0.07
2026-03-11	AHG	0	10.87	0.08
2026-03-12	AHG	0	10.87	0.08
2026-03-13	AHG	0	10.87	0.08
2026-03-17	AHG	0	10.82	0.08
2026-03-18	AHG	0	10.82	0.08
2026-03-19	AHG	0	10.82	0.08
2026-03-20	AHG	0	10.82	0.08
2026-03-23	AHG	0	11.44	0.08
2026-03-24	AHG	0	11.44	0.08
2026-03-25	AHG	0	11.44	0.21
2026-03-26	AHG	0	11.44	0.21
2026-03-27	AHG	0	11.44	0.21
2026-03-30	AHG	0	11.44	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

11.44

Beta

-1.05

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.6

Max Drawdown 5-Year %

-98.7

Target Price

P/E

Forward P/E

PEG

P/S

135.15

P/B

10.12

P/Free Cash Flow

277.59

EPS

-0.47

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-912.55

Relative Volume

2.95

Return on Equity vs Sector %

-95.9

Return on Equity vs Industry %

-406.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ AHG Healthcare

$2.35

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

3/15

Valuation

10/20

TP/AR

2/10

Options

0/10

RSI

64.5

Range 1M

83.9%

Sup Dist

3.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

11/30

Estimates

1/20

Inst/Vol

12/15

Options

0/10

EPS Yr

EPS NY

52W%

88.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +70.2% upside

Quality

3/30

Valuation

15/30

Growth

5/25

Stability

6/10

LT Trend

1/5

Upside

+70.2%

Quality

Akso Health Group

Sector: Healthcare

Industry: Medical Distribution

Employees: 27

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

AHG

Latest News

—

Caricamento notizie per AHG…

stock quote shares AHG – Akso Health Group Stock Price stock today

news today AHG – Akso Health Group stock forecast ,stock prediction 2023 2024 2025

marketwatch AHG – Akso Health Group yahoo finance google finance

stock history AHG – Akso Health Group invest stock market

stock prices AHG premarket after hours

ticker AHG fair value insiders trading

PBH – Prestige Consumer Healthcare Inc.

PBH — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.36

Margin Of Safety %

Put/Call OI Ratio

1.17

EPS Next Q Diff

-0.15

EPS Last/This Y

0.22

EPS This/Next Y

0.27

Price

58.56

Target Price

78.2

Analyst Recom

1.38

Performance Q

-6.88

Upside

-16.0%

Beta

0.49

Ticker: PBH

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	PBH	68.54	0.88	0.00	437
2026-03-03	PBH	69	0.88	0.00	437
2026-03-04	PBH	69.06	0.88	999.99	437
2026-03-05	PBH	67.95	1.02	0.00	469
2026-03-06	PBH	67.2	1.02	0.00	469
2026-03-09	PBH	66.2	0.96	1.42	483
2026-03-10	PBH	65.41	1.08	0.00	686
2026-03-11	PBH	64.79	1.08	0.00	687
2026-03-12	PBH	61.91	1.08	0.00	687
2026-03-13	PBH	61.9	1.08	0.00	687
2026-03-17	PBH	62.32	1.06	999.99	695
2026-03-18	PBH	60.79	1.07	999.99	699
2026-03-19	PBH	60.05	1.07	999.99	699
2026-03-20	PBH	60.99	1.07	999.99	700
2026-03-23	PBH	62.82	1.21	0.00	654
2026-03-24	PBH	62.01	1.17	0.00	665
2026-03-25	PBH	61.1	1.17	0.00	665
2026-03-26	PBH	60.41	1.17	0.00	665
2026-03-27	PBH	59.25	1.17	0.00	665
2026-03-30	PBH	58.51	1.17	0.00	665
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	PBH	68.54	5.6	27.7	4.54
2026-03-03	PBH	69.01	5.6	32.3	4.54
2026-03-04	PBH	69.06	5.6	30.7	4.54
2026-03-05	PBH	67.95	5.6	26.4	4.54
2026-03-06	PBH	67.17	5.6	27.6	4.54
2026-03-09	PBH	66.21	5.6	26.8	4.54
2026-03-10	PBH	65.41	5.6	27.5	4.54
2026-03-11	PBH	64.85	5.6	28.4	4.54
2026-03-12	PBH	61.89	5.6	19.0	4.54
2026-03-13	PBH	61.39	5.6	28.4	4.54
2026-03-17	PBH	62.37	5.6	36.6	4.54
2026-03-18	PBH	60.77	5.6	24.3	4.54
2026-03-19	PBH	60.05	5.6	27.6	4.54
2026-03-20	PBH	60.99	5.6	34.3	4.54
2026-03-23	PBH	62.79	5.6	37.9	4.54
2026-03-24	PBH	62.00	5.6	27.4	4.54
2026-03-25	PBH	61.09	5.3	26.8	4.54
2026-03-26	PBH	60.37	5.3	27.4	4.54
2026-03-27	PBH	59.25	5.3	25.9	4.54
2026-03-30	PBH	58.56	5.3	27.8	4.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	PBH	-0.70	-0.02	4.32
2026-03-03	PBH	-0.70	-0.02	4.32
2026-03-04	PBH	-0.70	-0.02	4.32
2026-03-05	PBH	-0.70	-0.02	4.32
2026-03-06	PBH	-0.70	-0.02	4.32
2026-03-09	PBH	-0.70	-0.01	4.32
2026-03-10	PBH	-0.70	-0.01	4.32
2026-03-11	PBH	-0.70	-0.01	5.10
2026-03-12	PBH	-0.70	-0.01	5.10
2026-03-13	PBH	-0.70	-0.01	5.10
2026-03-17	PBH	-0.70	0.01	5.10
2026-03-18	PBH	-0.70	0.01	5.10
2026-03-19	PBH	-0.70	0.01	5.10
2026-03-20	PBH	-0.70	0.01	5.10
2026-03-23	PBH	-0.70	0.01	5.10
2026-03-24	PBH	-0.70	0.01	5.10
2026-03-25	PBH	-0.70	0.01	5.36
2026-03-26	PBH	-0.70	0.01	5.36
2026-03-27	PBH	-0.70	0.01	5.36
2026-03-30	PBH	-0.70	0.01	5.36
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.14

Avg. EPS Est. Current Quarter

1.39

Avg. EPS Est. Next Quarter

0.99

Insider Transactions

-0.7

Institutional Transactions

0.01

Beta

0.49

Average Sales Estimate Current Quarter

294

Average Sales Estimate Next Quarter

254

Fair Value

74.9

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-35.5

Target Price

78.2

P/E

15.47

Forward P/E

12.15

PEG

2.85

P/S

2.51

P/B

1.51

P/Free Cash Flow

10.36

EPS

3.78

Average EPS Est. Cur. Y

4.54

EPS Next Y. (Est.)

4.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.9

Relative Volume

1.42

Return on Equity vs Sector %

-17.2

Return on Equity vs Industry %

3.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

27.8

◆ PBH Healthcare

$58.51

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

21/25

Volume

3/15

Valuation

20/20

TP/AR

2/10

Options

3/10

RSI

31.3

Range 1M

3.9%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

19/25

Growth

6/30

Estimates

5/20

Inst/Vol

4/15

Options

4/10

EPS Yr

0.4%

EPS NY

52W%

5.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +18.6% upside

Quality

13/30

Valuation

12/30

Growth

3/25

Stability

7/10

LT Trend

4/5

Upside

+18.6%

Quality

MoS

28%

Prestige Consumer Healthcare In

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 600

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH

Latest News

—

Caricamento notizie per PBH…

stock quote shares PBH – Prestige Consumer Healthcare Inc. Stock Price stock today

news today PBH – Prestige Consumer Healthcare Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PBH – Prestige Consumer Healthcare Inc. yahoo finance google finance

stock history PBH – Prestige Consumer Healthcare Inc. invest stock market

stock prices PBH premarket after hours

ticker PBH fair value insiders trading

PDCO – Patterson Companies, Inc.

PDCO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

3.53

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.43

EPS Last/This Y

EPS This/Next Y

Price

31.33

Target Price

31.35

Analyst Recom

Performance Q

1.42

Upside

N/A

Beta

0.62

Ticker: PDCO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	PDCO	31.33	N/A	N/A	0
2026-03-03	PDCO	31.33	N/A	N/A	0
2026-03-04	PDCO	31.33	N/A	N/A	0
2026-03-05	PDCO	31.33	N/A	N/A	0
2026-03-06	PDCO	31.33	N/A	N/A	0
2026-03-09	PDCO	31.33	N/A	N/A	0
2026-03-10	PDCO	31.33	N/A	N/A	0
2026-03-11	PDCO	31.33	N/A	N/A	0
2026-03-12	PDCO	31.33	N/A	N/A	0
2026-03-13	PDCO	31.33	N/A	N/A	0
2026-03-17	PDCO	31.33	N/A	N/A	0
2026-03-18	PDCO	31.33	N/A	N/A	0
2026-03-19	PDCO	31.33	N/A	N/A	0
2026-03-20	PDCO	31.33	N/A	N/A	0
2026-03-23	PDCO	31.33	N/A	N/A	0
2026-03-24	PDCO	31.33	N/A	N/A	0
2026-03-25	PDCO	31.33	N/A	N/A	0
2026-03-26	PDCO	31.33	N/A	N/A	0
2026-03-27	PDCO	31.33	N/A	N/A	0
2026-03-30	PDCO	31.33	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

Last Quarter Act. EPS

0.43

Avg. EPS Est. Current Quarter

0.85

Avg. EPS Est. Next Quarter

Insider Transactions

-0.02

Institutional Transactions

-6

Beta

0.62

Average Sales Estimate Current Quarter

1768

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.2

Max Drawdown 5-Year %

-40

Target Price

31.35

P/E

20.21

Forward P/E

PEG

P/S

0.43

P/B

2.8

P/Free Cash Flow

EPS

1.55

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.13

Relative Volume

Return on Equity vs Sector %

-7.2

Return on Equity vs Industry %

357.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

79.8

No data found for PDCO

PDCO

Latest News

—

Caricamento notizie per PDCO…

stock quote shares PDCO – Patterson Companies, Inc. Stock Price stock today

news today PDCO – Patterson Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PDCO – Patterson Companies, Inc. yahoo finance google finance

stock history PDCO – Patterson Companies, Inc. invest stock market

stock prices PDCO premarket after hours

ticker PDCO fair value insiders trading

HSIC – Henry Schein, Inc.

HSIC — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.5

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.14

EPS Last/This Y

2.03

EPS This/Next Y

0.54

Price

72.71

Target Price

Analyst Recom

2.38

Performance Q

-4.51

Upside

-1.0%

Beta

0.89

Ticker: HSIC

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	HSIC	81.33	0.29	0.33	4685
2026-03-03	HSIC	80.2	0.29	0.10	4696
2026-03-04	HSIC	80.74	0.29	44.25	4705
2026-03-05	HSIC	80.15	0.38	0.06	5060
2026-03-06	HSIC	77.63	0.38	0.11	5061
2026-03-09	HSIC	78.08	0.38	0.05	5054
2026-03-10	HSIC	76.27	0.39	2.47	5043
2026-03-11	HSIC	76.49	0.34	0.17	5152
2026-03-12	HSIC	74.86	0.34	1.33	5160
2026-03-13	HSIC	74.97	0.34	1.50	5160
2026-03-17	HSIC	74.88	0.35	0.00	5193
2026-03-18	HSIC	73.11	0.35	0.00	5187
2026-03-19	HSIC	72.68	0.23	0.17	7286
2026-03-20	HSIC	72.29	0.19	0.01	8086
2026-03-23	HSIC	74.46	0.16	0.01	5938
2026-03-24	HSIC	74.02	0.16	0.14	5978
2026-03-25	HSIC	74.22	0.16	0.27	5979
2026-03-26	HSIC	73.68	0.16	0.14	5992
2026-03-27	HSIC	72.08	0.16	2.58	5990
2026-03-30	HSIC	72.7	0.16	999.99	6029
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	HSIC	81.36	5.2	343.7	5.32
2026-03-03	HSIC	80.20	5.2	342.3	5.32
2026-03-04	HSIC	80.58	5.2	345.7	5.32
2026-03-05	HSIC	80.15	5.2	338.0	5.32
2026-03-06	HSIC	77.62	5.2	318.2	5.32
2026-03-09	HSIC	78.10	5.2	346.9	5.32
2026-03-10	HSIC	76.27	5.2	324.3	5.32
2026-03-11	HSIC	76.49	5.2	344.3	5.32
2026-03-12	HSIC	74.99	5.2	327.3	5.32
2026-03-13	HSIC	75.56	5.2	347.9	5.32
2026-03-17	HSIC	74.88	5.2	344.8	5.32
2026-03-18	HSIC	73.11	5.2	324.6	5.32
2026-03-19	HSIC	72.68	5.2	292.9	5.32
2026-03-20	HSIC	72.29	5.2	289.1	5.32
2026-03-23	HSIC	74.46	5.4	310.0	5.32
2026-03-24	HSIC	74.01	4.6	305.7	5.29
2026-03-25	HSIC	74.23	4.6	307.8	5.29
2026-03-26	HSIC	73.68	4.9	302.5	5.32
2026-03-27	HSIC	72.08	4.9	287.1	5.32
2026-03-30	HSIC	72.71	4.9	293.2	5.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	HSIC	-0.29	-4.61	4.89
2026-03-03	HSIC	-0.54	-4.61	4.89
2026-03-04	HSIC	-0.54	-4.61	4.89
2026-03-05	HSIC	-0.54	-4.61	4.89
2026-03-06	HSIC	-0.54	-4.61	4.89
2026-03-09	HSIC	-0.59	-4.60	4.89
2026-03-10	HSIC	-0.59	-4.60	4.89
2026-03-11	HSIC	-0.61	-4.60	4.27
2026-03-12	HSIC	-0.61	-4.60	4.27
2026-03-13	HSIC	-0.61	-4.60	4.27
2026-03-17	HSIC	-0.61	-4.57	4.27
2026-03-18	HSIC	-0.61	-4.57	4.27
2026-03-19	HSIC	-0.61	-4.57	4.27
2026-03-20	HSIC	-0.62	-4.57	4.27
2026-03-23	HSIC	-0.62	-4.56	4.27
2026-03-24	HSIC	-0.62	-4.56	4.27
2026-03-25	HSIC	-0.62	-4.56	5.50
2026-03-26	HSIC	-0.62	-4.56	5.50
2026-03-27	HSIC	-0.62	-4.56	5.50
2026-03-30	HSIC	-0.62	-4.56	5.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.21

Avg. EPS Est. Next Quarter

1.2

Insider Transactions

-0.62

Institutional Transactions

-4.56

Beta

0.89

Average Sales Estimate Current Quarter

3339

Average Sales Estimate Next Quarter

3371

Fair Value

88.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.5

Max Drawdown 5-Year %

-32.7

Target Price

P/E

22.23

Forward P/E

12.38

PEG

1.36

P/S

0.63

P/B

2.59

P/Free Cash Flow

14.55

EPS

3.27

Average EPS Est. Cur. Y

5.32

EPS Next Y. (Est.)

5.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.02

Relative Volume

0.7

Return on Equity vs Sector %

-15.2

Return on Equity vs Industry %

-325.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

293.2

◆ HSIC Healthcare

$72.70

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

21/25

Volume

9/15

Valuation

20/20

TP/AR

5/10

Options

4/10

RSI

38.7

Range 1M

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

12/25

Growth

13/30

Estimates

10/20

Inst/Vol

1/15

Options

4/10

EPS Yr

7.1%

EPS NY

10.3%

52W%

40.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +50.1% upside

Quality

6/30

Valuation

20/30

Growth

10/25

Stability

4/10

LT Trend

1/5

Upside

+50.1%

Quality

MoS

22%

Henry Schein, Inc.

Sector: Healthcare

Industry: Medical Distribution

Employees: 25000

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC

Latest News

—

Caricamento notizie per HSIC…

stock quote shares HSIC – Henry Schein, Inc. Stock Price stock today

news today HSIC – Henry Schein, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch HSIC – Henry Schein, Inc. yahoo finance google finance

stock history HSIC – Henry Schein, Inc. invest stock market

stock prices HSIC premarket after hours

ticker HSIC fair value insiders trading

OMI – Owens & Minor, Inc.

OMI — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

13.52

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-1.68

EPS Last/This Y

5.75

EPS This/Next Y

-0.05

Price

2.32

Target Price

5.64

Analyst Recom

Performance Q

-44.22

Upside

N/A

Beta

1.35

Ticker: OMI

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	OMI	2.8	N/A	N/A	0
2026-03-03	OMI	2.8	N/A	N/A	0
2026-03-04	OMI	2.8	N/A	N/A	0
2026-03-05	OMI	2.8	N/A	N/A	0
2026-03-06	OMI	2.8	N/A	N/A	0
2026-03-09	OMI	2.8	N/A	N/A	0
2026-03-10	OMI	2.8	N/A	N/A	0
2026-03-11	OMI	2.8	N/A	N/A	0
2026-03-12	OMI	2.8	N/A	N/A	0
2026-03-13	OMI	2.8	N/A	N/A	0
2026-03-17	OMI	2.8	N/A	N/A	0
2026-03-18	OMI	2.8	N/A	N/A	0
2026-03-19	OMI	2.8	N/A	N/A	0
2026-03-20	OMI	2.8	N/A	N/A	0
2026-03-23	OMI	2.8	N/A	N/A	0
2026-03-24	OMI	2.8	N/A	N/A	0
2026-03-25	OMI	2.8	N/A	N/A	0
2026-03-26	OMI	2.8	N/A	N/A	0
2026-03-27	OMI	2.8	N/A	N/A	0
2026-03-30	OMI	2.8	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

Last Quarter Act. EPS

1.83

Avg. EPS Est. Current Quarter

0.23

Avg. EPS Est. Next Quarter

0.15

Insider Transactions

106.79

Institutional Transactions

-4.17

Beta

1.35

Average Sales Estimate Current Quarter

714

Average Sales Estimate Next Quarter

654

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.3

Max Drawdown 5-Year %

-95.2

Target Price

5.64

P/E

Forward P/E

2.88

PEG

P/S

0.03

P/B

P/Free Cash Flow

EPS

-17.4

Average EPS Est. Cur. Y

1.02

EPS Next Y. (Est.)

0.97

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-19.98

Relative Volume

0.65

Return on Equity vs Sector %

284.8

Return on Equity vs Industry %

-124.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

498

No data found for OMI

OMI

Latest News

—

Caricamento notizie per OMI…

stock quote shares OMI – Owens & Minor, Inc. Stock Price stock today

news today OMI – Owens & Minor, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch OMI – Owens & Minor, Inc. yahoo finance google finance

stock history OMI – Owens & Minor, Inc. invest stock market

stock prices OMI premarket after hours

ticker OMI fair value insiders trading

No more stocks to show

COR – Cencora Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

AHG – Akso Health Group

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AHG

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y